SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000863894-19-000004
Filing Date
2019-02-13
Accepted
2019-02-13 14:22:04
Documents
72
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q veru-20181231x10q.htm 10-Q 1182273
2 EX-10.1 veru-20181231xex10_1.htm EX-10.1 177805
3 EX-31.1 veru-20181231xex31_1.htm EX-31.1 15743
4 EX-31.2 veru-20181231xex31_2.htm EX-31.2 15827
5 EX-32.1 veru-20181231xex32_1.htm EX-32.1 11543
  Complete submission text file 0000863894-19-000004.txt   6243470

Data Files

Seq Description Document Type Size
6 EX-101.INS veru-20181231.xml EX-101.INS 1330406
7 EX-101.SCH veru-20181231.xsd EX-101.SCH 52497
8 EX-101.CAL veru-20181231_cal.xml EX-101.CAL 55762
9 EX-101.DEF veru-20181231_def.xml EX-101.DEF 181388
10 EX-101.LAB veru-20181231_lab.xml EX-101.LAB 399857
11 EX-101.PRE veru-20181231_pre.xml EX-101.PRE 353603
Mailing Address 4400 BISCAYNE BOULEVARD SUITE 888 MIAMI FL 33137
Business Address 4400 BISCAYNE BOULEVARD STE 888 MIAMI FL 33137 3125959123
VERU INC. (Filer) CIK: 0000863894 (see all company filings)

IRS No.: 391144397 | State of Incorp.: WI | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-13602 | Film No.: 19596236
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1